NetworkNewsBreaks

TuesdayFeb 13, 2024 2:12 pm

NetworkNewsBreaks – GEMXX Corp. (GEMZ) Announces Groundbreaking Start for January Product Deliveries

GEMXX (OTC: GEMZ), a pioneering mine-to-market gold, gemstone and jewelry producer, today announced a stellar start to the year with impressive product deliveries worth $1,051,374 at retail for the month of January. According to the announcement, January’s deliveries mark an incredible 600% increase compared to the same period last year, highlighting GEMXX's strong growth trajectory and its effective business strategies. “Our January delivery results are a testament to the hard work and dedication of the GEMXX team,” said Jay Maull, CEO of GEMXX Corporation. “Our ability to achieve such significant deliveries is a clear indication of our competitive edge in…

Continue Reading

TuesdayFeb 13, 2024 2:02 pm

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Appoints Liat Halpert as Head of Business Development, Sales

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit, today announced the appointment of Liat Halpert as head of business development and sales. Halpert brings extensive pharmaceutical sales and marketing experience and joins Scinai following 14 years at Novartis, most recently having served as marketing and commercial excellence lead for cell and gene therapies for Central, Southern and Eastern Europe. “I am pleased to welcome Liat to Scinai,” said Amir Reichman, Scinai’s CEO. “Her pharmaceutical sales, marketing and leadership experience, in particular in…

Continue Reading

TuesdayFeb 13, 2024 1:55 pm

NetworkNewsBreaks – Lelantos Holdings Inc. (OTC: LNTO) Moves Forward on Eco Management Systems Acquisition, Appoints New Board Member

Lelantos Holdings (OTC: LNTO), a company with a focus on sustainable energy, is taking the first step in its acquisition of Eco Management Systems, a full-service commercial and residential solar contractor. According to the announcement, Lelantos executed a memorandum of understanding with Eco to acquire 50% of the company and is now finalizing formal binding agreements. Lelantos reports that acquiring Eco will allow the company to expand its operations as well as add a residential solar program to its offerings. The company is planning on finalizing the acquisition after the successful completion of key milestones that have been identified. Eco…

Continue Reading

TuesdayFeb 13, 2024 1:40 pm

NetworkNewsBreaks – ROTH MKM Provides D-Wave Quantum Inc. (NYSE: QBTS) Analyst Day Takeaways, Reiterates Buy Rating

ROTH MKM attended D-Wave Quantum Inc.’s (“D-Wave” or “QBTS”) annual analyst day recently held at the company’s research & development headquarters. Suji Desilva, CFA, Managing Director and Senior Research Analyst at ROTH MKM, published an update as part of the investment bank’s ongoing equity research coverage to provide investors with a summary of the visit. Excerpts of the report include the following: “We believe QBTS leads the industry with 70 commercial customers and has significant pipeline visibility with its 25+ proof-of-concepts underway.” “We were encouraged by multiple QBTS customer presentations that highlight deep and impactful adoption of quantum annealing (QA).”…

Continue Reading

TuesdayFeb 13, 2024 1:29 pm

NetworkNewsBreaks – WestPark Capital Reiterates Buy Rating on D-Wave Quantum Inc. (NYSE: QBTS), Recaps Analyst Day Visit

WestPark Capital recently published its recap of the recent analyst day event hosted by D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in the development and delivery of quantum computing systems, software and services. Highlights of the visit included discussions by several customers about the benefits they are experiencing by using D-Wave’s solutions, anticipation for the launch of the company’s next-generation quantum processor, additional opportunities in government, and a growing number of use cases that have the potential to expand the size of the market opportunity for D-Wave to $100 billion by 2030. A key excerpt of the report reads,…

Continue Reading

TuesdayFeb 13, 2024 1:10 pm

NetworkNewsBreaks – Astrotech Corp. (NASDAQ: ASTC) Releases Q2 2024 Financial Report

Astrotech (NASDAQ: ASTC), an innovative science and technology company, is releasing its financial results for Q2 2024, the period ended Dec. 31, 2023. Highlights of the report include a 512% increase in year-to-date revenue, which reached $1,540,000 compared to $301,000 in the same period in 2023; a strong consolidated balance sheet with $37 million in cash and liquid investments; and a year-to-date FY 2024 gross margin increase of 46% from 38% during the same period in 2023. In addition, the company reported that its 1st Detect subsidiary reentered detection and nondetection testing with the U.S. Transportation Security Administration (“TSA”) for cargo…

Continue Reading

TuesdayFeb 13, 2024 8:30 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Engages Global CRO to Support NDA Submission for Approval of Tonmya(TM) for Fibromyalgia Management

Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, has engaged Rho, Inc., a global contract research organization (“CRO”). Under the terms of the engagement, Rho will support Tonix in preparing its New Drug Application (“NDA”) for planned submission to the U.S. Food and Drug Administration (“FDA”) for the clearance of Tonmya(TM), a patented sublingual tablet formulation of cyclobenzaprine hydrochloride, for the management of fibromyalgia. “We are excited by our most recent positive Phase 3 study results of Tonmya and look forward to Rho’s support in preparing our NDA,” said Seth Lederman,…

Continue Reading

MondayFeb 12, 2024 3:35 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Patented DehydraTECH(TM) Improves Delivery of GLP-1 Drug to Bloodstream

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, announced the final results from its completed human Pilot Study #1 that sought to evaluate the effectiveness of its patented DehydraTECH(TM) technology on the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially in the branded product Rybelsus(R). “Most notable from its pilot study was the improved delivery of semaglutide to the bloodstream, which significantly improved blood sugar control. For one, in just 20 minutes after oral administration, the DehydraTECH-GLP-1 blood semaglutide level was about 261% higher than that of the control, a statistic that reflected…

Continue Reading

MondayFeb 12, 2024 3:18 pm

NetworkNewsBreaks – Turbo Energy S.A. (NASDAQ: TURB) Positioned at Industry Forefront with Focus on AI-Driven Optimization, Diverse Product Offerings

Turbo Energy (NASDAQ: TURB), a Spain-based energy storage innovator, maintained a streak of success in 2023 despite challenges in the self-consumption photovoltaic sector. “June witnessed the launch of its SunBox Industry product line, a strategic move targeting the commercial and industrial self-consumption market. In September, Turbo Energy successfully raised $5 million with its American Depositary Shares debiting on the Nasdaq Capital Market. October marked a milestone with the company securing a patent in Spain for its innovative residential photovoltaic software. November brought about a strategic partnership with Leroy Merlin and the introduction of Turbo Energy’s GoSolar offering through a collaboration…

Continue Reading

MondayFeb 12, 2024 3:00 pm

NetworkNewsBreaks – Software Effective Solutions Corp. (SFWJ) Committed to Building Capabilities to Provide Pharmaceutical-Grade Cannabis Extracts to the World

Software Effective Solutions (OTC: SFWJ) is among companies in the cannabis space paying close attention to the mounting calls for the rescheduling of cannabis to a Schedule III from a Schedule I substance per the Controlled Substances Act (“CSA”). “The call for cannabis rescheduling on the CSA list is not new, but it has gained momentum since the U.S. Department of Health and Human Services (‘HHS’) sent a brief letter to the head of the U.S. Drug Enforcement Administration… ‘HHS is believed to have advised DEA to move marijuana from Schedule I to Schedule III of the Controlled Substances Act…

Continue Reading